News

Genetic risk assessment delivers measurable value to consumers

Are currently available genomic testing services reliable? And can they deliver real value? Here we attempt to answer both questions comprehensively.

Negen partners with BC Platforms for early risk assessment of common diseases

Negen is excited to announce a cooperation agreement with BC Platforms, a leading provider of genomic data management and analytics. Negen’s advanced Genetic Risk Scoring tools will be integrated with BC Platforms’ state-of-the-art genomic data management platform, leading to advances in data processing and interpretation. Working together, these two leading genomics data companies will provide a premium, integrated solution to healthcare providers and customers around the world.